
Denovo Sciences
Armenian AI platform using reinforcement learning to design small-molecule drug candidates.
- Soha
- AI / ML, Biotech
- Joylashuv
- Armenia
Tasdiqlangan daromad: hali ulanmagan
Denovo Sciences sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.
Startap haqida
Denovo Sciences builds a reinforcement-learning platform that generates and screens candidate small molecules against protein or RNA targets for pharmaceutical clients, and plans to develop its own drug candidates. The company came out of the FAST ASCENT program in Armenia and was selected for EU4Innovation's VivaTech 2026 delegation. Co-founders are Hovakim Zakaryan (CEO), Mher Matevosyan (CTO) and Vardan Harutyunyan.
Jamoa
- Hovakim Zakaryan, Co-founder and CEO (Asoschi)
- Mher Matevosyan, Co-founder and CTO (Asoschi)
- Vardan Harutyunyan, Co-founder and CAIO (Asoschi)
Auditoriya
Ijtimoiy tarmoqlardagi kuzatuvchilar
- YouTube UCGygBfd6H1rD0mK7AcP7t_Q: ≈2 580 obunachi (Ochiq raqam, emrr YouTubedan oʻqigan (yaxlitlangan), 2026-yil 20-noyabr)
- Instagram @hellomyyoga
- X @hellomyyoga
- Facebook hellomyyoga
- LinkedIn denovo-sciences
Profil maʼlumotlari manbasi: Stanbase.